Skip to main content
. 2023 Mar;17(1):1–9. doi: 10.5704/MOJ.2303.001

Table III:

Laboratory variables of the study subjects in patients with fragility fracture (group-L) and patients with a high-energy fracture (group-H)

Sl. No. Variable Normal Range Group-L (n=124) Group-H (n=49) P-value
Mean (SD) N Mean (SD) N
1 Haemoglobin 14.0-17.5 g/dL 12.2 (1.9) 120 11.7 (1.5) 37 0.07
2 TLC 4.5-11.0 × 109/L 8.3 (2.0) 120 8.2 (2.1) 37 0.6
3 Neutrophils 48 % to 77% 63.0 (8.2) 115 64.0 (9.1) 35 0.5
4 Eosinophils 0.3 % to 7% 3.3 (2.3) 115 3.1 (2.0) 35 0.7
5 Lymphocytes 10 % to 40% 30.0 (7.8) 114 29.4 (7.6) 35 0.7
6 Monocytes 0.6 % to 9.6% 3.7 (2.2) 116 3.3 (2.3) 36 0.4
7 Platelet 150-450 ×103/μL 267.3 (143.9) 118 239.0 (115.0) 34 0.3
8 Urea 15-40mg/dl 30.9 (9.2) 121 33.8 (12) 36 0.1
9 Creatinine 0.6-1.2mg/dL 0.9 (2.7) 118 0.7 (0.3) 36 0.6
10 Estimated GFR >60mL/min/1.73m2 92.1 (17.8) 117 91.7 (22.9) 36 0.9
11 Albumin 3.4-5.0g/dL 3.9 (0.5) 119 3.8 (0.5) 37 0.5
12 Bilirubin 0.3-1.2mg/dL 0.7 (0.4) 120 0.8 (1.2) 37 0.4
13 AST 20-45U/L 29 (12.8) 121 27.5 (8.5) 37 0.5
14 ALT 10-40U/L 24.5 (16) 121 24.4 (11.7) 37 1.0
15 Sodium 136-142mEq/L 137.7 (12.7) 122 139.2 (6.2) 37 0.5
16 Potassium 3.5-5.0mEq/L 4.6 (0.5) 121 4.6 (0.5) 37 0.7
17 Phosphate 2.3-4.7mg/dL 3.8 (0.9) 123 4 (0.9) 36 0.6
18 Calcium 8.2-10.2mg/dL 9.8 (0.8) 122 9.7 (0.8) 37 0.4
19 Corrected calcium 8.2-10.2mg/dL 9.9 (0.8) 122 9.8 (0.7) 37 0.5
20 PTH 10-66pg/mL 31.6 (21) 108 29.2 (17.8) 39 0.5
21 Vitamin D 20-80ng/mL 44 (26.3) 106 48.5 (29.6) 38 0.4
22 ALP 50-129U/L 102.9 (37.1) 122 90.8 (29.3) 36 0.07

Abbreviations - N: Number of patients whose data were available, n: total number of subjects in the group. ALT: Alanine aminotransferase, ALP: Alkaline phosphatase, AST: Aspartate aminotransferase, GFR: Glomerular filtration rate, PTH: Parathyroid hormone, SD: Standard deviation, TLC: Total leucocyte count.